Display Settings:

Format

Send to:

Choose Destination
We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Am J Med. 2012 Jul;125(7 Suppl):S15-7. doi: 10.1016/j.amjmed.2012.04.017.

Why are myelodysplastic syndromes unrecognized and underdiagnosed? A primary care perspective.

Author information

  • Division of Hematology and Oncology, UAB Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, Alabama 35294-3300, USA. awaiskmd@gmail.com

Abstract

Primary care physicians (PCPs) may lack a basic understanding of myelodysplastic syndromes (MDS). Two case studies, presented to 44 internal medicine residents and outpatient attending internists, highlighted a potential knowledge gap. A differential diagnosis of MDS was overlooked in a 72-year-old man with several comorbidities and a hemoglobin level of 9.2 g/dL (historical levels, 10.8 to 11.2 g/dL). Despite the acute change in hemoglobin levels, and the presence of comorbid lung and heart disease, there was no immediate recommendation from the PCPs for specialist referral. In contrast, in the second case study a 76-year-old man with a 6-month history of recurrent infections, fatigue, a hemoglobin level of 7.2 g/dL, and multilineage cytopenias typifying the clinical presentation of MDS did receive further attention and workup. With these cases as background, this article examines the potential reasons for the failure of many PCPs to identify MDS, and suggests steps to be taken to improve its diagnosis, early referral, and treatment.

Copyright © 2012 Elsevier Inc. All rights reserved.

PMID:
22735746
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk